Biomedical / Clinical Engineering / HTM program outsourcing / insourcing assessment

Hospitals nationwide have increasingly turned to biomedical engineering and clinical engineering outsourcing as a way to achieve rapid cost savings and simplify operations. However, many are now facing the long-term consequences of this biomed outsourcing decision. As internal Healthcare Technology Management (HTM) programs are scaled back or dissolved, organizations often forfeit direct control over staffing, institutional knowledge, and day-to-day technology decisions. This loss of ownership reduces transparency into asset performance, service quality, and true total cost of ownership, gradually leading to higher overall expenses, slower response times, diminished flexibility, and elevated operational and patient safety risks.

CornerStone HTM Advisors supports hospitals in breaking free from this cycle by restoring clarity, control, and strategic direction within healthcare technology management. Rather than reverting to outdated or rigid models, we help organizations strengthen in-house HTM governance, staffing strategy, and data-driven decision-making while objectively evaluating the performance and cost of existing outsourced arrangements. Our advisory approach realigns technology management with the clinical mission, enabling healthcare leaders to replace reactive outsourcing decisions with sustainable, transparent HTM programs that safeguard patient care, stabilize long-term costs, and support consistent clinical excellence.